Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Viome acquires Circulate Health for precision medicine

PRIVATEAug 12, 2026•about 3 hours ago

Acquiring Company

Viome Life Sciences

Acquired Company

Circulate Health

Bellevue

SeattleOtherBiotechnologyHealth CareScience And EngineeringBiotechnologyHealth Carehospital & health care

Description

Viome Life Sciences has acquired Circulate Health, enhancing its capabilities in precision medicine. This acquisition unites Viome's diagnostics with Circulate's therapeutic plasma exchange platform. The integration aims to provide a comprehensive approach to health management, focusing on measurable outcomes and patient interventions.

Company Information

Company

Viome Life Sciences

Location

205 108TH AVE NE, SUITE 150

Bellevue, Washington, United States

About

Viome Life Sciences is a mission-driven systems biology company founded in 2016 to tackle the epidemic of chronic diseases, cancer, and aging. To help individuals improve their health and to better understand the root of chronic diseases, Viome is strategically split into two divisions. Viome Consumer Services is focused on growing its established consumer products including tests, nutrition plans, and supplements. Viome Health Sciences is devoted to advancing its precision diagnostics and therapeutics platform. By conducting mRNA analysis at a mass scale, Viome is digitizing human biology and ultimately stopping the onset and progression of chronic diseases. Recently, Viome garnered FDA Approval for its unique mRNA technology and AI platform to detect cancers and has already successfully developed over 30 predictive models for some of the most prominent chronic diseases. For more information, visit https://www.viomelifesciences.com/

Don't miss Viome Life Sciences's next move

Get an email the moment Viome Life Sciences makes an acquisition, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Viome Life Sciences's next move

Learn about Strategic plan

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Circulate Health?

Circulate Health was acquired by Viome Life Sciences, based in Bellevue. The deal was reported on August 12, 2026. Viome Life Sciences is a mission-driven systems biology company founded in 2016 to tackle the epidemic of chronic diseases, cancer, and aging. Viome Life Sciences is privately held and operates in Other.

When did Viome Life Sciences acquire Circulate Health?

Viome Life Sciences's acquisition of Circulate Health was reported on August 12, 2026. Viome Life Sciences has acquired Circulate Health, enhancing its capabilities in precision medicine. This acquisition unites Viome's diagnostics with Circulate's therapeutic plasma exchange platform. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Circulate Health do?

Circulate Health is a longevity startup specializing in therapeutic plasma exchange (TPE) to advance human healthspan and lifespan. It is privately held, operating in Biotechnology, and is based in Seattle.